Altered expression of zinc transporters-4 and -6 in mild cognitive impairment, early and late Alzheimer’s disease brain-Reference-Cited by-同舟云学术

Altered expression of zinc transporters-4 and -6 in mild cognitive impairment, early and late Alzheimer’s disease brain

Published:2006-01 Issue:3 Volume:140 Page:879-888
ISSN:0306-4522
Container-title:Neuroscience
language:en
Short-container-title:Neuroscience

Author:

Smith J.L.,Xiong S.,Markesbery W.R.,Lovell M.A.

Publisher

Elsevier BV

Subject

General Neuroscience

Reference49 articles.

1. Al, An, Cu, Mn, and Fe levels in brain in Alzheimer’s disease;Andrasi;Arch Gerontol Geriatr,1995

2. Consensus recommendations for the postmortem diagnosis of Alzheimer’s disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer’s Disease;Neurobiol Aging,1997

3. Release of endogenous Zn2+ from brain tissue during activity;Assaf;Nature,1984

4. Functional gamma-secretase complex assembly in Golgi/trans-Golgi network;Baulac;Neurobiol Dis,2003

5. Sex, hormones, and Alzheimer’s disease;Baum;J Gerontol A Biol Sci Med Sci,2005

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the brain’s zinc code: implications for cognitive function and disease;Frontiers in Biophysics;2024-06-12

2. A novel chromone Schiff base as Zn²⁺ turn‐on fluorescent chemosensor in a mixed solution;Luminescence;2024-03

3. Impact of micronutrients and nutraceuticals on cognitive function and performance in Alzheimer's disease;Ageing Research Reviews;2024-03

4. From zinc homeostasis to disease progression: Unveiling the neurodegenerative puzzle;Pharmacological Research;2024-01

5. Biometals in Alzheimer disease: emerging therapeutic and diagnostic potential of molybdenum and iodine;Journal of Translational Medicine;2023-05-27